<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of lower extremity chronic venous disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of lower extremity chronic venous disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of lower extremity chronic venous disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lowell S Kabnick, MD, FACS, FACPh</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sherry Scovell, MD, FACS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chronic venous disease refers to a wide spectrum of longstanding abnormalities. These morphologic abnormalities may result from venous hypertension; one of the etiologies of venous hypertension is reflux (superficial, deep) [<a href="#rid1">1-3</a>]. Vein-related problems may or may not be symptomatic and, when symptomatic, include a wide range of clinical signs that vary from minimal superficial venous dilation to chronic skin changes with ulceration.</p><p>An overview of chronic venous disease is provided. Additional detail is provided in the topic reviews that are linked throughout.</p><p class="headingAnchor" id="H333597404"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Inadequate muscle pump function, incompetent venous valves (reflux), venous thrombosis, or nonthrombotic venous obstruction are causes of elevated venous pressure (venous hypertension), which initiates a sequence of anatomic, physiologic, and histologic changes leading to vein dilation, skin changes, and/or skin ulceration. The factors that determine whether a given patient will progress from mild to more severe disease are largely unknown. (See <a class="local">'Clinical progression'</a> below and  <a class="medical medical_review" href="/d/html/8202.html" rel="external">"Pathophysiology of chronic venous disease"</a> and  <a class="medical medical_review" href="/d/html/8200.html" rel="external">"Post-thrombotic (postphlebitic) syndrome", section on 'Pathophysiology'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>Chronic vein abnormalities are present in up to 50 percent of individuals [<a href="#rid4">4-7</a>]. However, estimates of prevalence rates of chronic venous disease vary depending upon the population studied [<a href="#rid8">8</a>].</p><p>Epidemiologic studies typically focus on defined population subsets based upon the visible manifestations of venous disease. Study populations are generally limited to either those with mild abnormalities (telangiectasias, reticular veins), uncomplicated varicose veins with or without truncal reflux (eg, great saphenous), or chronic venous insufficiency (ie, chronic edema, skin changes, venous ulceration). While it is convenient to stratify the study of venous abnormalities in this manner, it is important to remember that these subsets represent varying levels of disease severity in a spectrum of a single pathology; risk factors for development are the same. </p><p>Telangiectasias and reticular veins are the most frequent manifestation (50 to 66 percent of individuals depending upon the population studied) and frequently occur in the absence of more severe signs of chronic venous disease (eg, varicose veins, skin changes) [<a href="#rid8">8,9</a>]. However, corona phlebectatica may be a sign of more advanced disease. </p><p>Varicose veins are present in 10 to 30 percent of the general population, with increasing rates in older individuals [<a href="#rid6">6,7</a>]. The incidence of chronic venous insufficiency with and without ulceration also increases with age [<a href="#rid10">10-17</a>]. In the United States, prevalence estimates vary from 15 to 80 percent of the population depending on study population [<a href="#rid18">18</a>]. In an international review, the pooled estimate of prevalence by CEAP classification  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>) was 9 percent for C0, 26 percent for C1, 19 percent for C2, 8 percent for C3, 4 percent for C5 and 0.46 percent for C6 [<a href="#rid19">19</a>]. Point prevalence estimates of venous ulceration in Western nations range from 0.02 to 1 percent [<a href="#rid15">15,16,20,21</a>], while the period prevalence is higher, between 1 and 5 percent [<a href="#rid20">20,22</a>]. Since venous ulceration can be recurrent as well as chronic, studies of point prevalence tend to underestimate the number of cases. </p><p>Chronic venous disease appears to affect females more commonly than males. Telangiectasias affect 56 to 71 percent of females versus 36 to 44 percent of males [<a href="#rid8">8,9</a>]. Varicose veins are generally thought to be more common in females; however, depending upon the population evaluated, males may have a higher rate [<a href="#rid5">5-7,23-25</a>]. Chronic venous insufficiency may also be more common in females; however, estimates may be influenced by female longevity [<a href="#rid15">15,16,20,26-28</a>]. In one population sample, the rate of moderate disease was twice as high among females, but the rate of severe disease was higher in males [<a href="#rid29">29</a>]. Males who worked as laborers had higher rates of severe disease compared with non-laborers. There were no ethnic differences for prevalence of moderate disease. </p><p class="headingAnchor" id="H3"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>The risk factors for developing chronic venous disease include advancing age, female sex, family history of venous disease, ligamentous laxity (eg, hernia, flat feet), prolonged standing, increased body mass index, smoking, lower extremity trauma, prior venous thrombosis (ie, post-thrombotic), some hereditary conditions (eg, Klippel-Trenaunay syndrome), high estrogen states, and higher parity [<a href="#rid5">5,6,9,19,30-44</a>]. The proportion of the population with obesity and chronic venous insufficiency is increasing, and patients with obesity are more likely to be symptomatic as a result of their venous disease [<a href="#rid45">45</a>]. </p><p>Prevalence rates appear to be lower in non-Western populations and lower in the Middle East and African populations [<a href="#rid19">19,46</a>]. Based upon these observations, it is widely thought that factors related to Western lifestyle such as prolonged standing and sitting increase the likelihood of developing chronic venous disease. However, a large population-based study in Scotland that examined multiple potential risk factors found no consistent relationship between varicose veins and these lifestyle risk factors [<a href="#rid24">24</a>].</p><p>In spite of the well-known association, a history of deep venous thrombosis is obtained in fewer than one-third of patients with severe clinical manifestations of chronic venous disease (ie, skin changes, ulcer) [<a href="#rid20">20,47,48</a>]. Duplex ultrasound in these patients may identify valvular insufficiency, chronic vein wall thickening, or chronic thrombosis indicative of post-thrombotic syndrome [<a href="#rid49">49-51</a>]. (See  <a class="medical medical_review" href="/d/html/8200.html" rel="external">"Post-thrombotic (postphlebitic) syndrome"</a>.)</p><p>Many studies have suggested a strong familial component [<a href="#rid9">9,24,29</a>]. In a case control study of 67 patients and their parents, the risk for varicose veins was 90 percent when both parents were affected, 25 percent for men and 62 percent for women when one parent was affected, and 20 percent if neither parent had varicose veins [<a href="#rid52">52</a>].</p><p>Other venous conditions can contribute to the development of dilated veins and skin changes and include venous wall degeneration (ie, venous aneurysm), arteriovenous (AV) shunt (eg, traumatic AV fistula, AV malformation), and non-thrombotic iliac vein obstruction (eg, May-Thurner syndrome) [<a href="#rid37">37,38</a>]. Telangiectasias associated with cutaneous pigmentation and atrophy can also result from radiation treatments or sequelae. (See  <a class="medical medical_review" href="/d/html/8217.html" rel="external">"Acquired arteriovenous fistula of the lower extremity"</a> and  <a class="medical medical_review" href="/d/html/15122.html" rel="external">"Arteriovenous malformations of the extremities"</a> and  <a class="medical medical_review" href="/d/html/110055.html" rel="external">"May-Thurner syndrome"</a>.)</p><p class="headingAnchor" id="H2154097222"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Lower extremity chronic venous disorders encompass an entire spectrum of morphologic and functional abnormalities of the venous system. </p><p class="headingAnchor" id="H2195882463"><span class="h2">Symptoms and signs</span><span class="headingEndMark"> — </span>Symptoms or findings include pain, leg heaviness, aching, swelling, skin dryness, tightness, itching, irritation, and muscle cramps. The clinical evaluation of the patient with lower extremity chronic venous disease is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Symptoms'</a>.)</p><p>Venous claudication, which is a severe deep pain and tightness typically in the thigh muscles with vigorous exercise, can occur in the setting of acute, severe venous obstruction or longstanding venous obstruction. (See  <a class="medical medical_review" href="/d/html/15223.html" rel="external">"Overview of iliocaval venous obstruction", section on 'Clinical features'</a>.)</p><p>Visible clinical signs of chronic venous disorders in increasing severity include dilated veins (eg, telangiectasia, varicose veins), leg edema, skin changes, and skin ulceration. The prevalence of symptoms and clinical signs of venous disease correlates with the presence of venous reflux (superficial, deep venous obstruction) identified on duplex ultrasound [<a href="#rid9">9,53</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Telangiectasias, reticular veins, small varicose veins</strong> – Telangiectasias and reticular veins are dilated intradermal and subdermal veins, respectively  (<a class="graphic graphic_picture graphicRef62119" href="/d/graphic/62119.html" rel="external">picture 1</a>). (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Telangiectasia/reticular veins (C1)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Varicose veins</strong> – Varicose veins are dilated, elongated, tortuous, subcutaneous veins ≥3 mm in diameter  (<a class="graphic graphic_picture graphicRef56463 graphicRef68551" href="/d/graphic/56463.html" rel="external">picture 2A-B</a>). (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Varicose veins (C2)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Edema</strong> – Dependent edema at the ankle is associated with venous reflux  (<a class="graphic graphic_picture graphicRef56758" href="/d/graphic/56758.html" rel="external">picture 3</a>), which may progress over time to include the calf region. In the early stages of chronic venous insufficiency, edema may be present only at the end of the day; however, with time it can become persistent throughout the day. (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Symptoms'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin changes, venous ulceration</strong> – Patients with severe edema, skin changes (pigmentation, dermatitis, lipodermatosclerosis)  (<a class="graphic graphic_picture graphicRef76901" href="/d/graphic/76901.html" rel="external">picture 4</a>), or ulceration  (<a class="graphic graphic_picture graphicRef71020" href="/d/graphic/71020.html" rel="external">picture 5</a>) are regarded as having chronic venous insufficiency (advanced venous disease) [<a href="#rid54">54</a>], which is associated with superficial and/or deep venous reflux and/or obstruction [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Chronic venous insufficiency'</a>.)</p><p></p><p class="headingAnchor" id="H1360242491"><span class="h2">Clinical and anatomic classification</span><span class="headingEndMark"> — </span>Patients are classified as asymptomatic or symptomatic. The visible signs of chronic venous disease are categorized as C0 to C6 (CEAP [Clinical, Etiologic, Anatomic, Pathophysiology] classification)  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>). Veins are described anatomically as axial (traversing caudal to cranial) versus nonaxial veins, superficial versus deep, and communicating (between named segments) or perforator (between superficial and deep)  (<a class="graphic graphic_figure graphicRef52340 graphicRef55019" href="/d/graphic/52340.html" rel="external">figure 1A-B</a>). The classification of lower extremity chronic venous disorders, including measures of clinical severity (eg, venous clinical severity scale), is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'CEAP classification'</a> and  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Measures of clinical severity'</a>.)</p><p class="headingAnchor" id="H4254757858"><span class="h2">Clinical progression</span><span class="headingEndMark"> — </span>The factors responsible for a transition from mild to more severe clinical manifestations, and whether there necessarily is a sequential progression, are not well known. Disease progression and increasing severity of symptoms appear to be related to the extent of venous valvular incompetence [<a href="#rid9">9,23,28,55-58</a>]. Varicose veins tend to remain more stable in the absence of superficial or deep venous reflux. In an observational study that followed 73 patients, the asymptomatic limb contralateral to the limb undergoing treatments for varicose veins developed varicose veins in approximately one half of the patients over a five-year follow-up period [<a href="#rid59">59</a>].</p><p>The Framingham Study examined participants for the presence of varicose veins every two years over a 16-year period. Over this time, 396 of 1720 men (23 percent) and 629 of 2102 women (30 percent) who were initially free from the condition developed varicose veins. However, the presence or absence of venous reflux was not evaluated. The two-year incidence of varicose veins was, on average, 39.4 per 1000 for men and 51.9 per 1000 for women. The incidence was highest in women 40 to 49 years of age [<a href="#rid5">5</a>].</p><p>Selected markers of inflammation may predict disease severity and progression. In a study of 80 patients, the serum fibrinogen-to-albumin ratio was a sensitive and specific marker (75 and 87.5 percent, respectively) for determining increasing CEAP classification [<a href="#rid60">60</a>]. The fibrinogen-to-albumin ratio was also a predictor of disease progression but is not commonly used in practice. </p><p class="headingAnchor" id="H8"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of chronic venous disease is suggested by the presence of typical symptoms (leg pain, fatigue, heaviness) and physical examination findings. (See <a class="local">'Symptoms and signs'</a> above.)</p><p>Venous duplex ultrasound examination confirms the diagnosis demonstrating the presence of venous reflux  (<a class="graphic graphic_table graphicRef139619" href="/d/graphic/139619.html" rel="external">table 2</a>) [<a href="#rid1">1,61-63</a>]. Most symptomatic patients should undergo venous duplex ultrasonography to evaluate the nature and extent of venous reflux, which impacts the choice of treatment. Any combination of superficial, perforator or deep venous reflux, or deep venous obstruction can be present. (See  <a class="medical medical_review" href="/d/html/8196.html" rel="external">"Diagnostic evaluation of lower extremity chronic venous disease"</a> and <a class="local">'Approach by presence and location of reflux'</a> below.)</p><p class="headingAnchor" id="H1862389298"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Visibly dilated superficial veins, in conjunction with typical symptoms, suggest chronic venous disease. The differential diagnosis of chronic venous disease includes many entities that can cause lower extremity pain, edema  (<a class="graphic graphic_table graphicRef53550" href="/d/graphic/53550.html" rel="external">table 3</a>), skin changes, or nonhealing wounds. (See  <a class="medical medical_review" href="/d/html/6878.html" rel="external">"Clinical manifestations and evaluation of edema in adults"</a> and  <a class="medical medical_review" href="/d/html/13680.html" rel="external">"Approach to the differential diagnosis of leg ulcers"</a> and  <a class="medical medical_review" href="/d/html/15079.html" rel="external">"Clinical assessment of chronic wounds", section on 'Differentiation of chronic ulcers'</a>.)</p><p>Conditions other than chronic venous disease that are associated with telangiectasias include systemic sclerosis, cirrhosis, hereditary hemorrhagic telangiectasia, and ataxia telangiectasia; however, these do not typically involve the lower extremities [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/d/html/1345.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)"</a> and  <a class="medical medical_review" href="/d/html/6233.html" rel="external">"Ataxia-telangiectasia"</a>.)</p><p class="headingAnchor" id="H1941717093"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H3440163742"><span class="h2">Approach by clinical severity</span><span class="headingEndMark"> — </span>Patients with chronic venous disorders are managed according to clinical severity and the nature and level of underlying venous reflux. </p><p class="headingAnchor" id="H2911183665"><span class="h3">Asymptomatic</span><span class="headingEndMark"> — </span>Some individuals with large, dilated veins (ie, varicosities) do not have significant complaints and may not find the appearance of their veins at all concerning. Others find even the smallest veins cosmetically troublesome, even in the absence of symptoms. </p><p>In the absence of symptoms, telangiectasias, reticular veins, and small varicose veins can generally be treated as desired to improve cosmetic appearance without further diagnostic studies as these patients are not as likely as patients with symptoms to have underlying venous reflux [<a href="#rid8">8,28</a>] However, such treatment generally requires being paid for out-of-pocket in the US. (See <a class="local">'No axial vein reflux'</a> below.) </p><p>Sclerotherapy and surface laser therapy of telangiectasias and reticular veins are generally considered cosmetic treatments and are not typically covered by insurance, though occasionally sclerotherapy will be reimbursed for treating veins that have bled [<a href="#rid65">65</a>]. Typically, several treatment sessions are required. It is important to note that such treatment does not prevent the future development of venous reflux and the occurrence of chronic venous disease. </p><p class="headingAnchor" id="H2813510189"><span class="h3">Symptomatic</span><span class="headingEndMark"> — </span>Initial nonoperative management is recommended for most symptomatic patients and may include skin care, leg elevation, exercise, and compression therapy [<a href="#rid1">1,3</a>]. Patients who have refractory symptom management should undergo comprehensive lower extremity duplex examination to confirm the diagnosis of chronic venous disease with the demonstration of venous reflux  (<a class="graphic graphic_table graphicRef139619" href="/d/graphic/139619.html" rel="external">table 2</a>) [<a href="#rid1">1</a>]. For patients with symptomatic varicose veins and axial venous reflux who are candidates, we suggest intervention.(See  <a class="medical medical_review" href="/d/html/15199.html" rel="external">"Compression therapy for the treatment of chronic venous insufficiency"</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Response to initial measures'</a>.)</p><p class="headingAnchor" id="H2990432646"><span class="h4">Chronic symptoms</span><span class="headingEndMark"> — </span>Whether to offer additional treatment for symptomatic venous disease depends upon the response to nonoperative management, ongoing symptoms, extent of disease, presence of reflux (superficial, deep, perforator), patient expectations, and likelihood that treatment would provide a durable benefit with respect to appearance or improvement in symptoms [<a href="#rid1">1</a>]. The majority of patients with chronic symptoms will exhibit some degree of venous reflux (superficial, deep), and some patients with skin changes or venous ulceration may have isolated saphenous incompetence and may be candidates for superficial venous ablation [<a href="#rid66">66,67</a>]. When offered, venous ablation for treatment of superficial venous reflux can be performed before or simultaneous with the management of visibly dilated veins. Treatment of large varicose veins prior to superficial venous ablation is appropriate when specific ablation techniques are used, such as ambulatory selective varicose vein ablation under local anesthesia (ASVLA) or Conservatrice et Hémodynamique de l'Insuffisance Veineuse en Ambulatoire (CHIVA). [<a href="#rid3">3</a>]. (See <a class="local">'With superficial venous reflux'</a> below.)</p><p>For patients with lipodermatosclerosis (C4b), healed ulcer (C5), or active ulcer (C6) following superficial venous ablation, treatment of refluxing perforator veins  (<a class="graphic graphic_table graphicRef139619" href="/d/graphic/139619.html" rel="external">table 2</a>) may offer a benefit [<a href="#rid68">68</a>]. However, not all patients with lipodermatosclerosis need perforator ablation. Appropriate candidates may include lipodermatosclerosis with impending skin breakdown when the incompetent perforating vein is directly under the affected area of skin.</p><p>Many clinicians approach venous obstruction first in patients with active ulceration (C6), before or at the same time as superficial truncal reflux. Options for treating deep venous reflux are few but treatment of deep venous obstruction may include endovenous intervention for proximal lesions (eg, iliac vein stenosis), or surgery to improve venous outflow. (See <a class="local">'With deep venous reflux'</a> below and <a class="local">'With perforator reflux'</a> below.)</p><p class="headingAnchor" id="H2589252480"><span class="h4">Bleeding</span><span class="headingEndMark"> — </span>Telangiectasias, reticular veins, or varicose veins that are superficial or located near bony prominences are easily traumatized and prone to bleeding. Bleeding from dilated superficial veins can generally be managed with direct pressure and elevation of the limb. If bleeding persists despite these measures, the bleeding point can be suture ligated, but fortunately the need for this is rare. </p><p>For patients with stigmata of recent venous bleeding or recurrent bleeding, sclerotherapy or vein excision can be used as a temporizing measure, depending upon the location and size of the vein [<a href="#rid69">69,70</a>]. Even in the presence of venous insufficiency, sclerotherapy reduces the risk of future bleeding at the treated site; however, reducing venous hypertension by eliminating the truncal reflux is the more optimal strategy [<a href="#rid8">8</a>]. Larger varicose veins are best treated with excision (phlebectomy). (See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Ambulatory phlebectomy'</a>.)</p><p>Once bleeding has been controlled, duplex examination should be performed to identify any underlying venous pathology (eg, reflux, obstruction), which can be treated to reduce the risk of recurrence. Additional treatments may be warranted to manage superficial venous or perforator reflux. (See <a class="local">'With superficial venous reflux'</a> below.)</p><p class="headingAnchor" id="H3157407830"><span class="h2">Approach by presence and location of reflux</span></p><p class="headingAnchor" id="H2058893957"><span class="h3">No axial vein reflux</span><span class="headingEndMark"> — </span>Patients with isolated varicose veins without axial vein (eg, great saphenous) reflux are typically treated with sclerotherapy or excision (phlebectomy), depending on vein size, location, and number of veins involved [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/8206.html" rel="external">"Injection sclerotherapy techniques for the treatment of telangiectasias, reticular veins, and small varicose veins"</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Ambulatory phlebectomy'</a>.)</p><p>For the treatment of most patients with lower extremity telangiectasias, reticular veins, and varicose veins , liquid sclerotherapy is often the preferred initial approach depending on the skills of the clinician. The results of sclerotherapy are generally thought to be superior to those of laser therapy. Thus, laser therapy is generally reserved for patients with a fear of needles, those who are allergic to sclerosing agents, have post-sclerotherapy matting, or have failed sclerotherapy. A combination therapy (cryolaser and cryosclerotherapy [ClaCS]) is becoming popularized for reticular veins and telangiectasia [<a href="#rid72">72</a>]. Outcomes depend upon the diameter of the vein being treated and the presence or absence of underlying reticular veins and skin type. (See  <a class="medical medical_review" href="/d/html/8176.html" rel="external">"Laser and light therapy of lower extremity telangiectasias, reticular veins, and small varicose veins", section on 'Laser versus sclerotherapy'</a>.)</p><p class="headingAnchor" id="H320009932"><span class="h3">With superficial venous reflux</span><span class="headingEndMark"> — </span>Patients with persistent symptoms and signs of chronic venous disease after a period of nonoperative management and documented superficial venous reflux as a source of their symptoms are candidates for superficial venous ablation. A decision to offer ablation therapy depends upon symptom severity, response to medical therapy, extent of disease, patient expectations, and likelihood of providing a durable benefit with respect to appearance or improvement in symptoms or ulcer healing. (See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Candidates for venous intervention'</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency"</a> and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Endovenous versus surgical ablation'</a>.)</p><p>Treatment of superficial venous reflux is typically accomplished in the office setting using one of several venous ablation techniques, which are classified by the nature and method of vein destruction, including non-thermal and thermal methods. Combination treatments have also been described [<a href="#rid73">73,74</a>]. Superficial venous ablation is thought to produce beneficial effects by reducing the venous volume in the limb and thereby the effects of venous hypertension on skin [<a href="#rid75">75</a>]. (See  <a class="medical medical_review" href="/d/html/15233.html" rel="external">"Comparison of methods for endovenous ablation for chronic venous disease"</a>.)</p><p>The timing of treatment of significant symptomatic telangiectasias, reticular veins, and varicose veins can be immediate with microphlebectomy or sclerotherapy at the same time as venous ablation, or as deferred treatment [<a href="#rid76">76,77</a>]. Delaying treatment may minimize the number of veins that need further treatment. Following successful ablation, residual telangiectasias, reticular veins, and small varicosities can become more prominent, but usually stabilize. Management of larger varicosities can also be delayed; however, it is equally appropriate to perform phlebectomy concurrently with ablation [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Treatment timing'</a>.)</p><p class="headingAnchor" id="H848989939"><span class="h3">With deep venous reflux</span><span class="headingEndMark"> — </span>For selected patients, endovenous treatment of central venous obstruction (eg, angioplasty/stenting) improves venous outflow and reduces symptoms. For post-thrombotic iliofemoral obstructive disease combined with superficial venous reflux, hemodynamics determines the course of treatment. Most interventionalists will initially relieve the deep venous obstruction and then consider superficial (saphenous) venous ablation, or ablation of a refluxing perforator. Management of iliocaval venous obstruction including compressive lesions (eg, May-Thurner) is reviewed separately. (See  <a class="medical medical_review" href="/d/html/110055.html" rel="external">"May-Thurner syndrome"</a> and  <a class="medical medical_review" href="/d/html/15223.html" rel="external">"Overview of iliocaval venous obstruction"</a> and  <a class="medical medical_review" href="/d/html/15222.html" rel="external">"Endovenous intervention for iliocaval venous obstruction"</a>.)</p><p>For those with <strong>severe</strong> deep venous reflux, venous reconstruction is another option that is moderately successful with acceptable morbidity [<a href="#rid79">79</a>]. Options include internal or external approaches to valve repair, as well as translocation of vein segments, transplantation of vein segments, and substitution. Other techniques under investigation include implantation of mechanical valves or endovenous creation of deep vein valves [<a href="#rid80">80</a>]. (See  <a class="medical medical_review" href="/d/html/15225.html" rel="external">"Techniques used for open iliocaval venous reconstruction"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with primary deep vein valvular incompetence can usually be treated with vein valve repair. It is worth noting that common femoral venous reflux is abolished in most patients who undergo great saphenous venous ablation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with secondary deep vein valvular incompetence (ie, following prior deep venous thrombosis) require more extensive transplantation or transposition procedures. </p><p></p><p>In general, better outcomes are achieved in patients with primary valvular incompetence compared with secondary incompetence with 10 year cumulative clinical success rates of 73 and 43 percent, respectively [<a href="#rid81">81,82</a>]. Such procedures are performed at a small number of academic centers by individuals who have dedicated their practice to the improvement of this difficult problem. </p><p class="headingAnchor" id="H5567098"><span class="h3">With perforator reflux</span><span class="headingEndMark"> — </span>Symptomatic patients whose physical examination and duplex study are consistent with perforator reflux  (<a class="graphic graphic_table graphicRef139619" href="/d/graphic/139619.html" rel="external">table 2</a>) as a source of impending skin breakdown, or venous ulceration, may be candidates for perforator ablation with ultrasound-guided sclerotherapy or endovenous methods. Incompetent perforators can contribute significantly to increased local venous pressure, reducing skin perfusion and inhibiting ulcer healing [<a href="#rid83">83</a>]. For patients with venous ulceration, incompetent perforator veins are less likely to be identified in isolation (incidence of 14 percent). When combined saphenous and perforator reflux are identified, saphenous venous reflux is treated first; perforator reflux often resolves following saphenous ablation [<a href="#rid83">83</a>]. Minimally invasive techniques for managing perforators are preferred rather than open surgical techniques [<a href="#rid84">84-87</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8203.html" rel="external">"Techniques for radiofrequency ablation for the treatment of lower extremity chronic venous disease", section on 'Perforator veins'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15198.html" rel="external">"Techniques for endovenous laser ablation for the treatment of lower extremity chronic venous disease", section on 'Perforator veins'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/129600.html" rel="external">"Nonthermal, nontumescent ablation techniques for the treatment of lower extremity superficial venous insufficiency", section on 'Perforator ablation'</a>.)</p><p></p><p>Isolated perforator reflux (ie, no saphenous or deep venous reflux), as a source of clusters of varicose veins, will often resolve when associated varicose veins are ablated or removed. Persistent or new perforators identified by duplex ultrasound following saphenous ablation can be managed concurrently with treatment of residual veins or later. </p><p class="headingAnchor" id="H3265099369"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118466.html" rel="external">"Society guideline links: Chronic venous disorders"</a>.)</p><p class="headingAnchor" id="H21453061"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15729.html" rel="external">"Patient education: Varicose veins and other vein disease in the legs (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/87610.html" rel="external">"Patient education: Vein ablation (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/2728.html" rel="external">"Patient education: Lower extremity chronic venous disease (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic venous disease</strong> – Visibly dilated lower extremity veins (ie, telangiectasias, reticular veins, varicose veins) can occur in the absence of symptoms or venous reflux but are often a source of significant distress to the patient. Significant symptoms (aching, swelling, heaviness) may be indicative of underlying venous insufficiency. Patients with skin changes or venous ulceration have chronic venous insufficiency, which may be due to superficial venous reflux, deep venous reflux, or a combination of these. (See <a class="local">'Clinical features'</a> above and <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous duplex</strong> – Symptomatic patients with lower extremity telangiectasias, reticular veins, varicose veins, skin changes, or venous ulceration should undergo further evaluation with venous duplex to identify the presence of superficial, perforator, or deep venous reflux, which alters treatment options. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Initial treatment for most patients is nonoperative and includes limb elevation, exercise, and compression therapy. Patients with persistent symptoms and signs of venous disease after a period of nonoperative management <strong>and</strong> documented superficial venous reflux as a source of their symptoms are candidates for superficial venous ablation. The primary goal of treatment is improvement in symptoms, but for some patients improved cosmetic appearance is also an important goal. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Axial vein ablation</strong> – For the elimination of superficial venous insufficiency due to axial venous reflux, endovenous ablation techniques are preferred to surgical vein stripping. Endovenous techniques are typically performed using local anesthesia in the office setting and are very successful in achieving vein closure and contributing to high rates of patient satisfaction. (See <a class="local">'With superficial venous reflux'</a> above and  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency", section on 'Technique selection by axial vein'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Perforator vein ablation</strong> – For the elimination of perforator reflux that remains following superficial venous ablation that is associated with an area of lipodermatosclerosis (C4b), or ulceration (C5,C6), ultrasound-guided sclerotherapy or endovenous method can be used. On occasion, surgical methods may be required for patients with recurrent or refractory venous ulceration. (See <a class="local">'With perforator reflux'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53:2S.</a></li><li><a class="nounderline abstract_t">Wittens C, Davies AH, Bækgaard N, et al. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015; 49:678.</a></li><li><a class="nounderline abstract_t">O'Donnell TF Jr, Passman MA. Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF)--Management of venous leg ulcers. Introduction. J Vasc Surg 2014; 60:1S.</a></li><li><a class="nounderline abstract_t">Zahariev T, Anastassov V, Girov K, et al. Prevalence of primary chronic venous disease: the Bulgarian experience. Int Angiol 2009; 28:303.</a></li><li><a class="nounderline abstract_t">Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 1988; 4:96.</a></li><li><a class="nounderline abstract_t">Callam MJ. Epidemiology of varicose veins. Br J Surg 1994; 81:167.</a></li><li><a class="nounderline abstract_t">Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999; 53:149.</a></li><li><a class="nounderline abstract_t">Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003; 158:448.</a></li><li><a class="nounderline abstract_t">Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg 2007; 46:322.</a></li><li><a class="nounderline abstract_t">Barwell JR, Taylor M, Deacon J, et al. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. Eur J Vasc Endovasc Surg 2000; 20:363.</a></li><li><a class="nounderline abstract_t">Zamboni P, Cisno C, Marchetti F, et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomized clinical trial. Eur J Vasc Endovasc Surg 2003; 25:313.</a></li><li><a class="nounderline abstract_t">Gohel MS, Barwell JR, Taylor M, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ 2007; 335:83.</a></li><li><a class="nounderline abstract_t">FEGAN WG. Continuous compression technique of injecting varicose veins. Lancet 1963; 2:109.</a></li><li><a class="nounderline abstract_t">Labas P, Ohradka B, Cambal M, et al. Long term results of compression sclerotherapy. Bratisl Lek Listy 2003; 104:78.</a></li><li><a class="nounderline abstract_t">Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed) 1985; 290:1855.</a></li><li><a class="nounderline abstract_t">Callam M. Prevalence of chronic leg ulceration and severe chronic venous disease in western countries. Phlebology 1992; 1(Suppl):6.</a></li><li><a class="nounderline abstract_t">Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic ulcer of the leg: clinical history. Br Med J (Clin Res Ed) 1987; 294:1389.</a></li><li><a class="nounderline abstract_t">Rabe E, Régnier C, Goron F, et al. The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey. J Comp Eff Res 2020; 9:1205.</a></li><li><a class="nounderline abstract_t">Salim S, Machin M, Patterson BO, et al. Global Epidemiology of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis. Ann Surg 2021; 274:971.</a></li><li><a class="nounderline abstract_t">Baker SR, Stacey MC, Jopp-McKay AG, et al. Epidemiology of chronic venous ulcers. Br J Surg 1991; 78:864.</a></li><li><a class="nounderline abstract_t">Cornwall JV, Doré CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986; 73:693.</a></li><li><a class="nounderline abstract_t">Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973; 48:839.</a></li><li><a class="nounderline abstract_t">Cesarone MR, Belcaro G, Nicolaides AN, et al. 'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology 2002; 53:119.</a></li><li><a class="nounderline abstract_t">Lee AJ, Evans CJ, Allan PL, et al. Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin Epidemiol 2003; 56:171.</a></li><li><a class="nounderline abstract_t">Carpentier PH, Maricq HR, Biro C, et al. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg 2004; 40:650.</a></li><li><a class="nounderline abstract_t">Dua A, Desai SS, Heller JA. The Impact of Race on Advanced Chronic Venous Insufficiency. Ann Vasc Surg 2016; 34:152.</a></li><li><a class="nounderline abstract_t">Dua A, Heller JA. Advanced Chronic Venous Insufficiency. Vasc Endovascular Surg 2017; 51:12.</a></li><li><a class="nounderline abstract_t">Langer RD, Ho E, Denenberg JO, et al. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med 2005; 165:1420.</a></li><li><a class="nounderline abstract_t">Criqui MH, Denenberg JO, Bergan J, et al. Risk factors for chronic venous disease: the San Diego Population Study. J Vasc Surg 2007; 46:331.</a></li><li><a class="nounderline abstract_t">Prochaska JH, Arnold N, Falcke A, et al. Chronic venous insufficiency, cardiovascular disease, and mortality: a population study. Eur Heart J 2021; 42:4157.</a></li><li><a class="nounderline abstract_t">Fukaya E, Flores AM, Lindholm D, et al. Clinical and Genetic Determinants of Varicose Veins. Circulation 2018; 138:2869.</a></li><li><a class="nounderline abstract_t">Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995; 22:622.</a></li><li><a class="nounderline abstract_t">Fowkes FG, Lee AJ, Evans CJ, et al. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. Int J Epidemiol 2001; 30:846.</a></li><li><a class="nounderline abstract_t">Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992; 18:883.</a></li><li><a class="nounderline abstract_t">Iannuzzi A, Panico S, Ciardullo AV, et al. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity. J Vasc Surg 2002; 36:965.</a></li><li><a class="nounderline abstract_t">Evans CJ, Fowkes FG, Hajivassiliou CA, et al. Epidemiology of varicose veins. A review. Int Angiol 1994; 13:263.</a></li><li><a class="nounderline abstract_t">Browse NL. The etiology of venous ulceration. World J Surg 1986; 10:938.</a></li><li><a class="nounderline abstract_t">Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982; 2:243.</a></li><li><a class="nounderline abstract_t">Darvall KA, Sam RC, Adam DJ, et al. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vasc Surg 2009; 49:1235.</a></li><li><a class="nounderline abstract_t">Allison MA, Cushman M, Callas PW, et al. Adipokines are associated with lower extremity venous disease: the San Diego population study. J Thromb Haemost 2010; 8:1912.</a></li><li><a class="nounderline abstract_t">Serra R, Buffone G, de Franciscis A, et al. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012; 26:636.</a></li><li><a class="nounderline abstract_t">Anwar MA, Georgiadis KA, Shalhoub J, et al. A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet 2012; 5:460.</a></li><li><a class="nounderline abstract_t">Vlajinac HD, Radak DJ, Marinkovic JM, Maksimovic MZ. Risk factors for chronic venous disease. Phlebology 2012; 27:416.</a></li><li><a class="nounderline abstract_t">Vlajinac HD, Marinkovic JM, Maksimovic MZ, et al. Body mass index and primary chronic venous disease--a cross-sectional study. Eur J Vasc Endovasc Surg 2013; 45:293.</a></li><li><a class="nounderline abstract_t">Davies HO, Popplewell M, Singhal R, et al. Obesity and lower limb venous disease - The epidemic of phlebesity. Phlebology 2017; 32:227.</a></li><li><a class="nounderline abstract_t">Stanhope JM. Varicose veins in a population of lowland New Guinea. Int J Epidemiol 1975; 4:221.</a></li><li><a class="nounderline abstract_t">Stacey MC, Burnand KG, Lea Thomas M, Pattison M. Influence of phlebographic abnormalities on the natural history of venous ulceration. Br J Surg 1991; 78:868.</a></li><li><a class="nounderline abstract_t">Hanrahan LM, Araki CT, Rodriguez AA, et al. Distribution of valvular incompetence in patients with venous stasis ulceration. J Vasc Surg 1991; 13:805.</a></li><li><a class="nounderline abstract_t">Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162:1144.</a></li><li><a class="nounderline abstract_t">Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164:17.</a></li><li><a class="nounderline abstract_t">Mohr DN, Silverstein MD, Heit JA, et al. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc 2000; 75:1249.</a></li><li><a class="nounderline abstract_t">Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994; 20:318.</a></li><li><a class="nounderline abstract_t">Labropoulos N, Giannoukas AD, Nicolaides AN, et al. The role of venous reflux and calf muscle pump function in nonthrombotic chronic venous insufficiency. Correlation with severity of signs and symptoms. Arch Surg 1996; 131:403.</a></li><li class="breakAll">Zenilman J, Valle MF, Malas MB, et al. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities. Report No: 13(14)-EHC121-EF, Agency for Healthcare Research and Quality (US); Rockland, MD 2013.</li><li><a class="nounderline abstract_t">Maurins U, Hoffmann BH, Lösch C, et al. Distribution and prevalence of reflux in the superficial and deep venous system in the general population--results from the Bonn Vein Study, Germany. J Vasc Surg 2008; 48:680.</a></li><li><a class="nounderline abstract_t">Wrona M, Jöckel KH, Pannier F, et al. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1. Eur J Vasc Endovasc Surg 2015; 50:360.</a></li><li><a class="nounderline abstract_t">Sarin S, Shields DA, Farrah J, et al. Does venous function deteriorate in patients waiting for varicose vein surgery? J R Soc Med 1993; 86:21.</a></li><li><a class="nounderline abstract_t">Labropoulos N, Leon L, Kwon S, et al. Study of the venous reflux progression. J Vasc Surg 2005; 41:291.</a></li><li><a class="nounderline abstract_t">Kostas TI, Ioannou CV, Drygiannakis I, et al. Chronic venous disease progression and modification of predisposing factors. J Vasc Surg 2010; 51:900.</a></li><li><a class="nounderline abstract_t">Karahan O, Yavuz C, Kankilic N, et al. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul Fibrinolysis 2016; 27:684.</a></li><li><a class="nounderline abstract_t">Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003; 38:793.</a></li><li><a class="nounderline abstract_t">Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21:635.</a></li><li><a class="nounderline abstract_t">Coleridge-Smith P, Labropoulos N, Partsch H, et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 2006; 31:83.</a></li><li><a class="nounderline abstract_t">Molho-Pessach V, Agha Z, Libster D, et al. Evidence for clinical and genetic heterogeneity in hereditary benign telangiectasia. J Am Acad Dermatol 2007; 57:814.</a></li><li class="breakAll">American Board of Plastic Surgery www.abplsurg.org/ModDefault.aspx (Accessed on March 31, 2009).</li><li><a class="nounderline abstract_t">Marston W, Fish D, Unger J, Keagy B. Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers. J Vasc Surg 2011; 53:1303.</a></li><li><a class="nounderline abstract_t">Gloviczki P, Bergan JJ, Menawat SS, et al. Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry. J Vasc Surg 1997; 25:94.</a></li><li><a class="nounderline abstract_t">Gohel MS, Heatley F, Liu X, et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. N Engl J Med 2018; 378:2105.</a></li><li><a class="nounderline abstract_t">Labas P, Cambal M. Profuse bleeding in patients with chronic venous insufficiency. Int Angiol 2007; 26:64.</a></li><li><a class="nounderline abstract_t">Hamahata A, Yamaki T, Osada A, et al. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins. Eur J Vasc Endovasc Surg 2011; 41:856.</a></li><li class="breakAll">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm435082.htm (Accessed on March 19, 2015).</li><li><a class="nounderline abstract_t">Miyake RK, Chi YW, Franklin IJ, Gianesini S. State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment. J Vasc Surg Venous Lymphat Disord 2020; 8:893.</a></li><li><a class="nounderline abstract_t">Zhu HP, Zhou YL, Zhang X, et al. Combined endovenous laser therapy and pinhole high ligation in the treatment of symptomatic great saphenous varicose veins. Ann Vasc Surg 2014; 28:301.</a></li><li><a class="nounderline abstract_t">Mueller RL, Raines JK. ClariVein mechanochemical ablation: background and procedural details. Vasc Endovascular Surg 2013; 47:195.</a></li><li><a class="nounderline abstract_t">Stacey MC, Burnand KG, Layer GT, Pattison M. Calf pump function in patients with healed venous ulcers is not improved by surgery to the communicating veins or by elastic stockings. Br J Surg 1988; 75:436.</a></li><li><a class="nounderline abstract_t">Galland RB, Magee TR, Lewis MH. A survey of current attitudes of British and Irish vascular surgeons to venous sclerotherapy. Eur J Vasc Endovasc Surg 1998; 16:43.</a></li><li><a class="nounderline abstract_t">Tisi PV, Beverley CA. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev 2002; :CD001732.</a></li><li><a class="nounderline abstract_t">Aherne TM, Ryan ÉJ, Boland MR, et al. Concomitant vs. Staged Treatment of Varicose Tributaries as an Adjunct to Endovenous Ablation: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg 2020; 60:430.</a></li><li><a class="nounderline abstract_t">Goel RR, Abidia A, Hardy SC. Surgery for deep venous incompetence. Cochrane Database Syst Rev 2015; :CD001097.</a></li><li><a class="nounderline abstract_t">Weber B, Hafner J, Willenberg T, Hoerstrup SP. Bioengineered valves for the venous circulation. Expert Rev Med Devices 2016; 13:1005.</a></li><li><a class="nounderline abstract_t">Masuda EM, Kistner RL. Long-term results of venous valve reconstruction: a four- to twenty-one-year follow-up. J Vasc Surg 1994; 19:391.</a></li><li><a class="nounderline abstract_t">Eklof BG, Kistner RL, Masuda EM. Venous bypass and valve reconstruction: long-term efficacy. Vasc Med 1998; 3:157.</a></li><li><a class="nounderline abstract_t">O'Donnell TF Jr. The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption. J Vasc Surg 2008; 48:1044.</a></li><li><a class="nounderline abstract_t">Thibault PK, Lewis WA. Recurrent varicose veins. Part 2: Injection of incompetent perforating veins using ultrasound guidance. J Dermatol Surg Oncol 1992; 18:895.</a></li><li><a class="nounderline abstract_t">Guex JJ. Ultrasound guided sclerotherapy (USGS) for perforating veins (PV). Hawaii Med J 2000; 59:261.</a></li><li><a class="nounderline abstract_t">van Gent WB, Catarinella FS, Lam YL, et al. Conservative versus surgical treatment of venous leg ulcers: 10-year follow up of a randomized, multicenter trial. Phlebology 2015; 30:35.</a></li><li><a class="nounderline abstract_t">Neto FC, de Araújo GR, Kessler IM, et al. Treatment of severe chronic venous insufficiency with ultrasound-guided foam sclerotherapy: a two-year series in a single center in Brazil. Phlebology 2015; 30:113.</a></li></ol></div><div id="topicVersionRevision">Topic 8181 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21536172" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25920631" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25064456" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF)--Management of venous leg ulcers. Introduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19648874" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of primary chronic venous disease: the Bulgarian experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3395496" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The epidemiology of varicose veins: the Framingham Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8156326" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Epidemiology of varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10396491" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12936900" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Chronic venous disease in an ethnically diverse population: the San Diego Population Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17600668" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11035968" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12651168" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17545185" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13944696" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Continuous compression technique of injecting varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12839217" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Long term results of compression sclerotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3924283" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Chronic ulceration of the leg: extent of the problem and provision of care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Prevalence of chronic leg ulceration and severe chronic venous disease in western countries</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3109669" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Chronic ulcer of the leg: clinical history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33079592" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33214466" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Global Epidemiology of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1873720" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Epidemiology of chronic venous ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3756430" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Leg ulcers: epidemiology and aetiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4744789" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Venous thromboembolism and other venous disease in the Tecumseh community health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11952101" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : 'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12654412" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15472591" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27179983" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The Impact of Race on Advanced Chronic Venous Insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28024458" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Advanced Chronic Venous Insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983292" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Relationships between symptoms and venous disease: the San Diego population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17600666" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Risk factors for chronic venous disease: the San Diego Population Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34387673" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Chronic venous insufficiency, cardiovascular disease, and mortality: a population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30566020" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical and Genetic Determinants of Varicose Veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7494366" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Risk factors for chronic venous insufficiency: a dual case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11511615" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1430543" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Predisposing factors of varicose and telangiectatic leg veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12422106" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7822904" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidemiology of varicose veins. A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3798942" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The etiology of venous ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6124673" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The cause of venous ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19307088" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20546124" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Adipokines are associated with lower extremity venous disease: the San Diego population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22664280" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A genetic study of chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22896013" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A review of familial, genetic, and congenital aspects of primary varicose vein disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22345329" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Risk factors for chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23337196" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Body mass index and primary chronic venous disease--a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27178403" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Obesity and lower limb venous disease - The epidemic of phlebesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1184273" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Varicose veins in a population of lowland New Guinea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1873721" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Influence of phlebographic abnormalities on the natural history of venous ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2038103" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Distribution of valvular incompetence in patients with venous stasis ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12020185" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14718318" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Relationship between deep venous thrombosis and the postthrombotic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11126832" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176043" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Importance of the familial factor in varicose disease. Clinical study of 134 families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8615726" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The role of venous reflux and calf muscle pump function in nonthrombotic chronic venous insufficiency. Correlation with severity of signs and symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8615726" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The role of venous reflux and calf muscle pump function in nonthrombotic chronic venous insufficiency. Correlation with severity of signs and symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18586443" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Distribution and prevalence of reflux in the superficial and deep venous system in the general population--results from the Bonn Vein Study, Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26141786" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8423569" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Does venous function deteriorate in patients waiting for varicose vein surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15768012" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Study of the venous reflux progression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20347686" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Chronic venous disease progression and modification of predisposing factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26650463" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14560232" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Definition of venous reflux in lower-extremity veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7707568" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16226898" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17658662" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Evidence for clinical and genetic heterogeneity in hereditary benign telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17658662" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Evidence for clinical and genetic heterogeneity in hereditary benign telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21215568" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9013912" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29688123" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A Randomized Trial of Early Endovenous Ablation in Venous Ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17353890" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Profuse bleeding in patients with chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21420881" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21420881" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179040" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24183454" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Combined endovenous laser therapy and pinhole high ligation in the treatment of symptomatic great saphenous varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23509062" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : ClariVein mechanochemical ablation: background and procedural details.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3390674" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Calf pump function in patients with healed venous ulcers is not improved by surgery to the communicating veins or by elastic stockings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9715715" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A survey of current attitudes of British and Irish vascular surgeons to venous sclerotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869605" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Injection sclerotherapy for varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32771286" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Concomitant vs. Staged Treatment of Varicose Tributaries as an Adjunct to Endovenous Ablation: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25702915" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Surgery for deep venous incompetence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27686743" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Bioengineered valves for the venous circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8126852" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Long-term results of venous valve reconstruction: a four- to twenty-one-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9796079" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Venous bypass and valve reconstruction: long-term efficacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18992425" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1430545" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Recurrent varicose veins. Part 2: Injection of incompetent perforating veins using ultrasound guidance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10916243" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Ultrasound guided sclerotherapy (USGS) for perforating veins (PV).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25729066" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Conservative versus surgical treatment of venous leg ulcers: 10-year follow up of a randomized, multicenter trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24335090" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Treatment of severe chronic venous insufficiency with ultrasound-guided foam sclerotherapy: a two-year series in a single center in Brazil.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
